Construction and characterization of an anti-CD20 mAb nanocomb with exceptionally excellent lymphoma-suppressing activity
Hua-Fei Li,1–3,* Cong Wu,4,* Ting Chen,5,* Ge Zhang,1 He Zhao,1 Chang-Hong Ke,1 Zheng Xu21International Joint Cancer Institute, Translation Medicine Institute, 2Planning Division, Scientific Research Department, 3Tumor Immunology and Gene Therapy Center, Eastern Hepatobiliary Surgery Hospi...
Main Authors: | Li H, Wu C, Chen T, Zhang G, Zhao H, Ke C, Xu Z |
---|---|
Format: | Article |
Language: | English |
Published: |
Dove Medical Press
2015-07-01
|
Series: | International Journal of Nanomedicine |
Online Access: | http://www.dovepress.com/construction-and-characterization-of-an-anti-cd20-mab-nanocomb-with-ex-peer-reviewed-article-IJN |
Similar Items
-
Rituximab and Other New Anti-CD20 MAbs for Non-Hodgkin’s Lymphoma Treatment
by: Letizia Polito, et al.
Published: (2013-10-01) -
Zinc oxide nanocomb biosensor for glucose detection
by: Wang, J. X., et al.
Published: (2011) -
Growth and characterization of ultra-long ZnO nanocombs
by: Shuming Yang, et al.
Published: (2016-06-01) -
B cell depletion with anti-CD20 mAb exacerbates anti-donor CD4+ T cell responses in highly sensitized transplant recipients
by: Asuka Tanaka, et al.
Published: (2021-09-01) -
Anti-CD40 mAb enhanced efficacy of anti-PD1 against osteosarcoma
by: Jingzhe Zhang, et al.
Published: (2019-08-01)